GB exhibits an immune-privileged nature characterized by limited lymphocytic infiltration, cytotoxic T cell exhaustion, recruitment of pro-tumorigenic TAMs, downregulation of cancer cells’ MHC I complexes, and abundance of immune-inhibitory molecules such as IL-10 and TGFβ. The gene discussed is TGFB1; the disease is cancer.